Relationship between anthropometric indices and macular optical coherence tomography angiography in healthy adults from the PERSIAN cohort study Authors: Hamid Reza Heidarzadeh, Elaheh Ebrahimi Miandehi, Nasser Shoeibi, Mohammad Reza Ansari-Astaneh, Seyedeh Maryam Hosseini, Majid Abrishami, Mehrdad Motamed Shariati, Reza Rezvani, Saeid Eslami, Mohammad Kasra Rezaei, MohammadReza Hoseinkhani, Amirsadra Zangouei, Mojtaba Abrishami Published: 2025 ABSTRACT To evaluate the association between optical coherence tomography angiography (OCTA) measured macular vessel density (VD) and fovea avascular zone (FAZ) parameters and several body composition parameters and anthropometric indices, using data from a large population-based cohort of seemingly healthy adults. A cross-sectional observational study utilized data from 424 participants in the PERSIAN Cohort Study. OCTA scans, with dimensions of 3 × 3 mm and 6 × 6 mm, were employed to assess macular VD in the superficial capillary plexus (SCP), deep capillary plexus (DCP), and parameters of the FAZ. Body composition was evaluated through bio-impedance analysis with the InBody 770 analyzer. The relationships between OCTA metrics and anthropometric indices were analyzed using multiple regression and correlation techniques with false discovery rate correction. The study population had a mean age of 39.3 ± 7.7 years, with 47% identifying as male. The results indicated that males displayed higher SCP VD at the fovea. A noteworthy positive correlation was found between foveal SCP VD and factors such as skeletal muscle mass, basal metabolic rate, and waist-hip ratio. In contrast, the whole-image DCP VD and FAZ areas were negatively correlated with total body water, fat-free mass, and muscle mass. The findings suggest that macular microvasculature is influenced by age, sex, and various anthropometric characteristics. These results highlight the potential of OCTA in evaluating systemic health and vascular status through retinal imaging. Further research is needed to investigate these findings’ underlying mechanisms and clinical applications.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-025-32194-5. Introduction Anthropometric indices are noninvasive quantitative external measurements of the body’s morphological traits, providing a valuable assessment of nutritional and metabolic status. Typically, they are used to evaluate the general health status and nutritional adequacy1. The core elements of anthropometry include weight, height, body mass index (BMI), head circumference, body circumferences to assess adiposity (waist, hip, and limb), neck circumferences, and skinfold thickness. Moreover, body composition indexes using bio-impedance evaluation, including basal metabolic rate (BMR), body fat free mass (FFM), body fat mass (BFM), body fat percentage (BFP), trunk fat and total body water (TBW) are measurable using an InBody body composition analyzer2,3. These indices help evaluate body’s metabolic status. Optical coherence tomography angiography (OCTA), serves as a potential non-invasive and rapid imaging modality for assessing microvascular changes in different retinal capillary levels4,5. By segmenting and selecting different en-face slabs from various retinal layers, OCTA enables depth-resolved visualization of the retinal microvasculature. Microvascular changes in the superficial, intermediate, and deep capillary plexuses can be evaluated individually. Retinal OCTA findings have been shown to correlate with several ocular pathologies, including glaucoma, diabetic retinopathy, and other retinal diseases, as well as systemic diseases like Alzheimer’s disease and COVID-19 infection4,6–11. To the best of our knowledge, no study exists on the correlation between anthropometric and body composition indexes and macular OCTA parameters. To fill this gap, our study aimed to investigate the relationship between InBody bio-impedance evaluation, macular vessel density (VD), and foveal avascular zone (FAZ). Methods Study participants Healthy adults participating in the PERSIAN Organizational Cohort Study of Mashhad (POCM) were subjects of our cross-sectional study conducted at Mashhad University of Medical Sciences (MUMS). POCM contains extensive information on baseline status and regular checkups of 12,000 employees (aged 30–70 years) in different organizations of MUMS in Mashhad, northeast of Iran. The detailed national protocol has been published in an article by Poustchi et al.12. Subjects provided ocular and systemic histories, as well as demographic data. Excluded participants had chronic systemic diseases, were pregnant or breastfeeding, had evidence of glaucoma, clinically apparent retinal disease, or a history of refractive or intraocular surgery. Additional criteria were absolute spherical refractive error greater than five diopters, cylindrical myopic refractive error of more than six diopters, and hyperopic refractive error of more than four diopters. Imaging technique The AngioVue OCTA system (RTVue XR Avanti with AngioVue software, Optovue Inc., Fremont, CA, USA; software version 2018.0.0.14; https://www.visionix.com) was used for all OCTA imagings. The system captured OCTA images at an A-scan rate of 70,000 scans per second, using a light source of 840 nm and a 45 nm bandwidth. The device acquires two consecutive B-scans at the same position to generate the flow map and reduce motion/projection inconsistencies. We conducted macular cube scans in horizontal and vertical directions using AngioRetina 3 × 3 and 6 × 6 mm scan protocols with AngioVue 3D Projection Artifact Removal. Automated default segmentation was used for measurements with preset superficial capillary plexus (SCP) and deep capillary plexus (DCP) settings. FAZ parameters (area, perimeter, and acircularity index) were automatically delineated by the AngioVue RTVue XR Avanti software within the total retinal slab—defined from the internal limiting membrane through the outer plexiform layer—using the manufacturer’s default segmentation settings. We then quantified for each FAZ: Area (the surface area of the avascular zone in mm²), Perimeter (the length of its boundary in mm), and Acircularity index (AI) (the ratio of the FAZ’s actual perimeter to that of a circle with the same area; unitless, with values > 1 indicating increasing departure from circularity). The study analyzed only the data from the right eye’s VDs. We acquired OCTA scans from both eyes and initially computed mean vessel density values across eyes. However, scan quality was consistently superior in right-eye images compared to left. Consequently, in accordance with established ophthalmic research guidelines13,14, we elected to use only right-eye vessel density metrics for all subsequent analyses correlating OCTA parameters with anthropometric indices. Only high-quality images centered on the fovea and with a scan quality index of at least 7/10 were included. Image review ensured sufficient resolution and accuracy, excluding any low-quality or motion-affected images. Retina subspecialists checked all images for segmentation errors. We measured various features from the AngioAnalytic report, including FAZ area, FAZ perimeter, FAZ acircularity index (AI), foveal VD-300 (FD-300) area density (foveal vessel density in a 300 μm ring around the FAZ), and FD-300 length density, as well as VD of the macula at the SCP and DCP levels. The fovea is the central 1 mm circle in the macula, with parafovea and perifovea being defined as rings around the fovea with diameters of 3 mm and 6 mm, respectively. We used 3 × 3 mm scans to extrapolate VD and FAZ data for the fovea and parafovea. Additionally, we utilized 6 × 6 mm scans to evaluate the VD in the perifoveal region. Anthropometric and body composition test Body composition was assessed using the InBody 770 body analyzer (InBody Co., Ltd., Seoul, South Korea; https://inbodyusa.com/products/inbody770). It uses a weak alternating current (50–1000 kHz) and evaluates the different masses of body tissues by measuring the reflected current, like muscle, fat, protein, body water, and minerals. The machine also calculates the BMR (lowest sustainable energetic expenditure of maintaining the body), FFM, BFM, BFP, trunk fat, and TBW. Whole Body Phase Angle (PhA) is a novel marker of cellular function, which represents the quality of soft tissue, with higher values reflecting better cell function. During bio-impedance measurement, participants were required to stand motionless, keeping the standard position. They were asked to abstain from caffeine consumption for at least 24 h and any drink or food for at least 4 h before the test. The height was measured in a standing position with elevated shoulders and in inspiration using a wall tape recorded in centimeters. Weight was measured parallel with body composition analysis using a digital bio-impedance analyzer (In Body 770) with light clothes and to the nearest 0.1 kg. The circumference around the widest part of the buttocks was measured for hip circumference measurement. Other measurements, such as abdominal, neck, arm, and chest circumferences, were measured to the nearest one decimal point in centimeters, according to the standard protocol of the POCM and based on National Institutes of Health protocols. At the same time, the participant was shoeless and had light underclothes3. All the measurements were recorded in centimeters. The person who conducted the measurements was trained and expert and has been approved by the scientific team of the POCM center. The pregnant women and the patients who had implanted pacemakers were excluded from the body analysis. Resting brachial blood pressure, central blood pressure, and pulse wave velocity were assessed separately in our companion PERSIAN cohort study15 but those data are beyond the scope of the present anthropometric analysis. Statistical analysis We examined variable distribution using the Shapiro-Wilk test and variance normality plots and checked for homogeneity using Levene’s test. We used independent-sample t-test and one-way ANOVA for comparisons based on data distribution and type, with statistical significance set at 0.05. The Pearson correlation coefficient test measured the correlation between study parameters. All statistical analyses were performed using IBM SPSS Statistics for Windows, Version 16.0 (IBM Corp., Armonk, NY, USA; https://www.ibm.com/products/spss-statistics). To address multiple testing across the large set of correlations and sectoral comparisons, we applied the Benjamini–Hochberg false discovery rate (FDR) correction with q = 0.05. FDR was controlled within families of related tests:1 for each OCTA outcome (e.g., foveal SCP VD, parafoveal DCP VD, FAZ metrics) across all anthropometric/body-composition predictors within a given scan size (3 × 3 or 6 × 6), and2 for all between-sex comparisons within each table. In tables, P† denotes the FDR-adjusted P-value. Unless otherwise specified, statistical significance refers to FDR-adjusted results. Ethical considerations The study followed the principles of the Declaration of Helsinki. The Regional Committee on Medical Ethics at Mashhad University of Medical Sciences, Mashhad, Iran (IR.MUMS.MEDICAL.REC.1401.229) approved the ethical aspects of the study. All participants provided written informed consent. Results Our study involved 424 healthy adults, with a mean age of 39.3 ± 7.7 years, comprising 197 males and 227 females. The demographic data of the participants is presented in Table 1. The male group exhibited significantly higher mean values for both height and weight. However, the groups had no statistically significant differences regarding mean age and BMI. Table 1 also outlines the mean values obtained from the InBody 770 body analyzer for both male and female groups. The male participants demonstrated significantly higher values for TBW, intracellular water (ICW), extracellular water (ECW), minerals, soft lean mass (SLM), FFM, skeletal muscle mass (SMM), BMR, waist-hip ratio (WHR), PhA, neck circumference (NC), chest circumference (CC), abdomen circumference (AC), and hip circumference (HC). In contrast, the female group showed significantly higher BFM, percent body fat (PBF), and visceral fat area (VFA) values. Table 2 Provides the values from the 3 × 3 mm and 6 × 6 mm OCTA scans for all participants and for male and female subgroups. The mean scan quality across all participants was 8.5 ± 0.7 for the 3 × 3 mm scans and 8.3 ± 0.7 for the 6 × 6 mm scans. In the 3 × 3 mm scans, the mean VDs for the SCP and the DCP were recorded at 45.8 ± 2.6% and 50.1 ± 3%, respectively. No significant differences were observed between males and females in the mean SCP VD sectors, except the fovea, where males displayed a higher mean SCP VD, and the parafovea superior sector, where females showed a higher mean SCP VD. In terms of the mean whole image DCP VD and all DCP VD sectors, females exhibited significantly higher values, except for the fovea DCP VD, which was significantly higher in males. Furthermore, the FAZ area, FAZ perimeter, and FD-300 were notably greater in females. In the 6 × 6 mm scans, the mean whole image SCP VD was significantly higher in females; however, no statistically significant difference was found in the mean whole image DCP VD between the two groups. Additionally, all perifoveal sectors revealed significantly higher mean SCP VD values in females. Table 1Demographic and anthropometric data of participants. P† = Benjamini–Hochberg FDR-adjusted P (q = 0.05).Total(n = 424)Male(n = 197)Female(n = 227)P-valueP†-valueAge (Year)39.3 ± 7.739.5 ± 5.939.4 ± 6.80.8640.926Height (cm)166.3 ± 9.7174.6 ± 5.9159.2 ± 5.8 < 0.001 0.002 Weight (kg)72.4 ± 12.879.8 ± 11.765.9 ± 9.7 < 0.001 0.002 Body Mass Index (BMI) (kg/m2)26.1 ± 3.526.2 ± 3.526 ± 3.50.5940.685Total Body Water (TBW) (kg)35.9 ± 7.842.9 ± 5.129.8 ± 3.6 < 0.001 0.002 Intracellular Water (ICW) (kg)22.3 ± 526.8 ± 3.218.4 ± 2.3 < 0.001 0.002 Extracellular Water (ECW) (kg)13.6 ± 2.916.1 ± 1.911.4 ± 1.4 < 0.001 0.002 Protein (kg)9.6 ± 2.29.7 ± 2.19.6 ± 2.30.9190.960Minerals (kg)3.4 ± 0.74 ± 0.52.9 ± 0.4 < 0.001 0.002 Body Fat Mass (BFM) (kg)23.4 ± 7.221.4 ± 7.525.2 ± 6.6 < 0.001 0.002 Soft Lean Mass (SLM) (kg)46.1 ± 10.155.2 ± 6.538.3 ± 4.6 < 0.001 0.002 Fat Free Mass (FFM) (kg)48.9 ± 10.758.4 ± 740.7 ± 4.9 < 0.001 0.002 Skeletal Muscle Mass (SMM) (kg)27.1 ± 6.532.9 ± 4.222.1 ± 2.9 < 0.001 0.002 Percent Body Fat (PBF) (%)32.4 ± 8.226.2 ± 6.337.8 ± 5.5 < 0.001 0.002 Basal Metabolic Rate (BMR) (kcal)1426.8 ± 230.71632.2 ± 150.41248.5 ± 106.2 < 0.001 0.002 Waist-Hip Ratio (WHR)0.94 ± 0.120.98 ± 0.110.90 ± 0.18 < 0.001 0.002 Visceral Fat Area (VFA) (cm2)111.7 ± 40.994.9 ± 37.4126.2 ± 38.3 < 0.001 0.002 Whole Body Phase Angle (PhA) (degree)5.6 ± 0.76 ± 0.55.2 ± 0.5 < 0.001 0.002 Neck Circumference (NC) (cm)36.5 ± 338.4 ± 2.134.8 ± 2.6 < 0.001 0.002 Chest Circumference (CC) (cm)96.5 ± 7.6101.3 ± 6.292.4 ± 6 < 0.001 0.002 Abdomen Circumference (AC) (cm)91.4 ± 9.994.3 ± 10.588.8 ± 8.7 < 0.001 0.002 Hip Circumference (HC) (cm)98.8 ± 5.9100.8 ± 5.797.1 ± 5.5 < 0.001 0.002 Table 1Demographic and anthropometric data of participants. P† = Benjamini–Hochberg FDR-adjusted P (q = 0.05).Total(n = 424)Male(n = 197)Female(n = 227)P-valueP†-valueAge (Year)39.3 ± 7.739.5 ± 5.939.4 ± 6.80.8640.926Height (cm)166.3 ± 9.7174.6 ± 5.9159.2 ± 5.8 < 0.001 0.002 Weight (kg)72.4 ± 12.879.8 ± 11.765.9 ± 9.7 < 0.001 0.002 Body Mass Index (BMI) (kg/m2)26.1 ± 3.526.2 ± 3.526 ± 3.50.5940.685Total Body Water (TBW) (kg)35.9 ± 7.842.9 ± 5.129.8 ± 3.6 < 0.001 0.002 Intracellular Water (ICW) (kg)22.3 ± 526.8 ± 3.218.4 ± 2.3 < 0.001 0.002 Extracellular Water (ECW) (kg)13.6 ± 2.916.1 ± 1.911.4 ± 1.4 < 0.001 0.002 Protein (kg)9.6 ± 2.29.7 ± 2.19.6 ± 2.30.9190.960Minerals (kg)3.4 ± 0.74 ± 0.52.9 ± 0.4 < 0.001 0.002 Body Fat Mass (BFM) (kg)23.4 ± 7.221.4 ± 7.525.2 ± 6.6 < 0.001 0.002 Soft Lean Mass (SLM) (kg)46.1 ± 10.155.2 ± 6.538.3 ± 4.6 < 0.001 0.002 Fat Free Mass (FFM) (kg)48.9 ± 10.758.4 ± 740.7 ± 4.9 < 0.001 0.002 Skeletal Muscle Mass (SMM) (kg)27.1 ± 6.532.9 ± 4.222.1 ± 2.9 < 0.001 0.002 Percent Body Fat (PBF) (%)32.4 ± 8.226.2 ± 6.337.8 ± 5.5 < 0.001 0.002 Basal Metabolic Rate (BMR) (kcal)1426.8 ± 230.71632.2 ± 150.41248.5 ± 106.2 < 0.001 0.002 Waist-Hip Ratio (WHR)0.94 ± 0.120.98 ± 0.110.90 ± 0.18 < 0.001 0.002 Visceral Fat Area (VFA) (cm2)111.7 ± 40.994.9 ± 37.4126.2 ± 38.3 < 0.001 0.002 Whole Body Phase Angle (PhA) (degree)5.6 ± 0.76 ± 0.55.2 ± 0.5 < 0.001 0.002 Neck Circumference (NC) (cm)36.5 ± 338.4 ± 2.134.8 ± 2.6 < 0.001 0.002 Chest Circumference (CC) (cm)96.5 ± 7.6101.3 ± 6.292.4 ± 6 < 0.001 0.002 Abdomen Circumference (AC) (cm)91.4 ± 9.994.3 ± 10.588.8 ± 8.7 < 0.001 0.002 Hip Circumference (HC) (cm)98.8 ± 5.9100.8 ± 5.797.1 ± 5.5 < 0.001 0.002 Demographic and anthropometric data of participants. P† = Benjamini–Hochberg FDR-adjusted P (q = 0.05). Table 2The right eye 3 × 3 mm and 6 × 6 mm OCTA scan values in males and females. P† = Benjamini–Hochberg FDR-adjusted P (q = 0.05). OCTA: optical coherence tomography angiography, VD: vessel density, SCP: superficial capillary plexus, DCP: deep capillary plexus, FAZ: foveal avascular zone, AI: acircularity index, FD-300: foveal vessel density-300.OCTA ParameterTotal(n = 424)Male(n = 197)Female(n = 227)P-valueP†-value3 × 3 mm ScanScan Quality8.5 ± 0.78.4 ± 0.78.6 ± 0.7 0.007 0.010 Whole Image SCP VD (%)45.8 ± 2.645.7 ± 2.845.8 ± 2.50.6530.726Superior Hemifield SCP VD (%)45.6 ± 2.745.6 ± 2.845.7 ± 2.50.7260.792Inferior Hemifield SCP VD (%)45.9 ± 2.845.8 ± 346 ± 2.60.6230.705Fovea SCP VD (%)17.3 ± 5.819 ± 5.415.8 ± 5.7 < 0.001 0.002 Parafovea SCP VD (%)48.6 ± 2.848.5 ± 348.8 ± 2.60.2600.318Parafovea Superior Hemifield SCP VD (%)48.5 ± 2.848.4 ± 348.7 ± 2.70.2380.297Parafovea Inferior Hemifield SCP VD (%)48.7 ± 348.6 ± 3.248.9 ± 2.70.3150.378Parafovea Temporal SCP VD (%)47.1 ± 2.947.1 ± 3.247.1 ± 2.60.9420.960Parafovea Superior SCP VD (%)49.9 ± 3.149.5 ± 3.250.2 ± 2.9 0.031 0.043 Parafovea Nasal SCP VD (%)47.8 ± 347.8 ± 347.9 ± 2.90.9440.960Parafovea Inferior SCP VD (%)49.8 ± 3.349.5 ± 3.650 ± 30.0740.101Whole Image DCP VD (%)50.1 ± 349.4 ± 3.250.6 ± 2.7 < 0.001 0.002 Whole Image Superior Hemifield DCP VD (%)49.9 ± 3.149.3 ± 3.250.4 ± 2.8 < 0.001 0.002 Whole Image Inferior Hemifield DCP VD (%)50.2 ± 3.149.5 ± 3.350.8 ± 2.8 < 0.001 0.002 Fovea DCP VD (%)33.1 ± 735 ± 6.431.4 ± 7.2 < 0.001 0.002 Parafovea DCP VD (%)52.2 ± 351.3 ± 3.153.1 ± 2.7 < 0.001 0.002 Parafovea Superior Hemifield DCP VD (%)52.2 ± 3.151.2 ± 3.153 ± 2.7 < 0.001 0.002 Parafovea Inferior Hemifield DCP VD (%)52.3 ± 3.151.3 ± 3.253.1 ± 2.8 < 0.001 0.002 Parafovea Temporal DCP VD (%)52.7 ± 2.851.8 ± 2.953.5 ± 2.5 < 0.001 0.002 Parafovea Superior DCP VD (%)51.6 ± 3.450.6 ± 3.652.4 ± 3.1 < 0.001 0.002 Parafovea Nasal DCP VD (%)52.8 ± 351.8 ± 3.153.6 ± 2.7 < 0.001 0.002 Parafovea Inferior DCP VD (%)51.8 ± 3.450.7 ± 3.652.7 ± 3.1 < 0.001 0.002 FAZ Area (mm2)0.3 ± 0.10.2 ± 0.10.3 ± 0.1 < 0.001 0.002 FAZ Perimeter (mm)2.1 ± 0.42 ± 0.42.2 ± 0.4 < 0.001 0.002 AI1.12 ± 0.51.13 ± 0.41.11 ± 0.60.1270.166FD-300(%)50.3 ± 3.449.8 ± 3.550.8 ± 3.2 0.002 0.003 6 × 6 mm ScanScan Quality8.3 ± 0.78.1 ± 0.68.4 ± 0.7 < 0.001 0.002 Whole Image SCP VD (%)49 ± 2.848.3 ± 2.849.5 ± 2.7 < 0.001 0.002 Perifovea Temporal SCP VD (%)45.9 ± 3.145.4 ± 3.246.4 ± 2.9 0.001 0.002 Perifovea Superior SCP VD (%)49.1 ± 3.548.3 ± 3.549.8 ± 3.3 < 0.001 0.002 Perifovea Nasal SCP VD (%)53.6 ± 2.953 ± 2.954.1 ± 2.9 < 0.001 0.002 Perifovea Inferior SCP VD (%)50 ± 3.349.4 ± 3.250.5 ± 3.2 0.001 0.002 Whole Image DCP VD (%)49 ± 4.348.7 ± 4.149.2 ± 4.40.1770.226Perifovea Temporal DCP VD (%)54.1 ± 3.953.6 ± 3.854.5 ± 3.9 0.024 0.034 Perifovea Superior DCP VD (%)48.9 ± 548.9 ± 4.848.9 ± 5.10.9990.999Perifovea Nasal DCP VD (%)47.7 ± 5.247.2 ± 5.148.1 ± 5.30.1000.133Perifovea Inferior DCP VD (%)50.1 ± 5.549.9 ± 5.250.2 ± 5.70.5450.641 Table 2The right eye 3 × 3 mm and 6 × 6 mm OCTA scan values in males and females. P† = Benjamini–Hochberg FDR-adjusted P (q = 0.05). OCTA: optical coherence tomography angiography, VD: vessel density, SCP: superficial capillary plexus, DCP: deep capillary plexus, FAZ: foveal avascular zone, AI: acircularity index, FD-300: foveal vessel density-300.OCTA ParameterTotal(n = 424)Male(n = 197)Female(n = 227)P-valueP†-value3 × 3 mm ScanScan Quality8.5 ± 0.78.4 ± 0.78.6 ± 0.7 0.007 0.010 Whole Image SCP VD (%)45.8 ± 2.645.7 ± 2.845.8 ± 2.50.6530.726Superior Hemifield SCP VD (%)45.6 ± 2.745.6 ± 2.845.7 ± 2.50.7260.792Inferior Hemifield SCP VD (%)45.9 ± 2.845.8 ± 346 ± 2.60.6230.705Fovea SCP VD (%)17.3 ± 5.819 ± 5.415.8 ± 5.7 < 0.001 0.002 Parafovea SCP VD (%)48.6 ± 2.848.5 ± 348.8 ± 2.60.2600.318Parafovea Superior Hemifield SCP VD (%)48.5 ± 2.848.4 ± 348.7 ± 2.70.2380.297Parafovea Inferior Hemifield SCP VD (%)48.7 ± 348.6 ± 3.248.9 ± 2.70.3150.378Parafovea Temporal SCP VD (%)47.1 ± 2.947.1 ± 3.247.1 ± 2.60.9420.960Parafovea Superior SCP VD (%)49.9 ± 3.149.5 ± 3.250.2 ± 2.9 0.031 0.043 Parafovea Nasal SCP VD (%)47.8 ± 347.8 ± 347.9 ± 2.90.9440.960Parafovea Inferior SCP VD (%)49.8 ± 3.349.5 ± 3.650 ± 30.0740.101Whole Image DCP VD (%)50.1 ± 349.4 ± 3.250.6 ± 2.7 < 0.001 0.002 Whole Image Superior Hemifield DCP VD (%)49.9 ± 3.149.3 ± 3.250.4 ± 2.8 < 0.001 0.002 Whole Image Inferior Hemifield DCP VD (%)50.2 ± 3.149.5 ± 3.350.8 ± 2.8 < 0.001 0.002 Fovea DCP VD (%)33.1 ± 735 ± 6.431.4 ± 7.2 < 0.001 0.002 Parafovea DCP VD (%)52.2 ± 351.3 ± 3.153.1 ± 2.7 < 0.001 0.002 Parafovea Superior Hemifield DCP VD (%)52.2 ± 3.151.2 ± 3.153 ± 2.7 < 0.001 0.002 Parafovea Inferior Hemifield DCP VD (%)52.3 ± 3.151.3 ± 3.253.1 ± 2.8 < 0.001 0.002 Parafovea Temporal DCP VD (%)52.7 ± 2.851.8 ± 2.953.5 ± 2.5 < 0.001 0.002 Parafovea Superior DCP VD (%)51.6 ± 3.450.6 ± 3.652.4 ± 3.1 < 0.001 0.002 Parafovea Nasal DCP VD (%)52.8 ± 351.8 ± 3.153.6 ± 2.7 < 0.001 0.002 Parafovea Inferior DCP VD (%)51.8 ± 3.450.7 ± 3.652.7 ± 3.1 < 0.001 0.002 FAZ Area (mm2)0.3 ± 0.10.2 ± 0.10.3 ± 0.1 < 0.001 0.002 FAZ Perimeter (mm)2.1 ± 0.42 ± 0.42.2 ± 0.4 < 0.001 0.002 AI1.12 ± 0.51.13 ± 0.41.11 ± 0.60.1270.166FD-300(%)50.3 ± 3.449.8 ± 3.550.8 ± 3.2 0.002 0.003 6 × 6 mm ScanScan Quality8.3 ± 0.78.1 ± 0.68.4 ± 0.7 < 0.001 0.002 Whole Image SCP VD (%)49 ± 2.848.3 ± 2.849.5 ± 2.7 < 0.001 0.002 Perifovea Temporal SCP VD (%)45.9 ± 3.145.4 ± 3.246.4 ± 2.9 0.001 0.002 Perifovea Superior SCP VD (%)49.1 ± 3.548.3 ± 3.549.8 ± 3.3 < 0.001 0.002 Perifovea Nasal SCP VD (%)53.6 ± 2.953 ± 2.954.1 ± 2.9 < 0.001 0.002 Perifovea Inferior SCP VD (%)50 ± 3.349.4 ± 3.250.5 ± 3.2 0.001 0.002 Whole Image DCP VD (%)49 ± 4.348.7 ± 4.149.2 ± 4.40.1770.226Perifovea Temporal DCP VD (%)54.1 ± 3.953.6 ± 3.854.5 ± 3.9 0.024 0.034 Perifovea Superior DCP VD (%)48.9 ± 548.9 ± 4.848.9 ± 5.10.9990.999Perifovea Nasal DCP VD (%)47.7 ± 5.247.2 ± 5.148.1 ± 5.30.1000.133Perifovea Inferior DCP VD (%)50.1 ± 5.549.9 ± 5.250.2 ± 5.70.5450.641 The right eye 3 × 3 mm and 6 × 6 mm OCTA scan values in males and females. P† = Benjamini–Hochberg FDR-adjusted P (q = 0.05). OCTA: optical coherence tomography angiography, VD: vessel density, SCP: superficial capillary plexus, DCP: deep capillary plexus, FAZ: foveal avascular zone, AI: acircularity index, FD-300: foveal vessel density-300. Table 3 presents the correlation between macula VD values derived from 3 × 3 mm and 6 × 6 mm OCTA scans and various InBody 770 parameters (All processed data supporting this study are included in Supplementary Tables S1–S3). Considering the data from 3 × 3 mm scan, the fovea SCP and DCP VDs demonstrated a significant positive correlation with TBW, ECW, minerals, FFM, SMM, BMR, WHR, PhA, NC, CC, AC, and HC. In contrast, these VDs negatively correlated with PBF. While the mean whole image SCP VD value did not reveal any significant correlations, the mean whole image DCP VD, along with the FAZ area, FAZ perimeter, and FD-300 values, showed a significant negative correlation with TBW, ICW, ECW, minerals, FFM, SMM, BMR, NC, CC, AC, and HC. Additionally, these parameters displayed a significant positive correlation with PBF. The data from 6 × 6 mm scan, showed that the mean VDs for the whole image SCP and DCP exhibited significant negative correlations with ECW, NC, and CC. Additionally, the whole image SCP VD demonstrated notable negative correlations with TBW, ICW, minerals, FFM, SMM, and BMR. Conversely, it displayed a significant positive correlation with PBF, a correlation that was not found in the whole image DCP VD. Although several correlations remained statistically significant after controlling the false discovery rate, the effect sizes were small, with most absolute correlation coefficients in the |r| ≈ 0.10–0.27 range, indicating that these variables explain only a limited proportion of variance in OCTA metrics. Table 3Correlation of the inbody 770 body analyzer parameters and the macular OCTA imaging parameters in 3 × 3 and 6 × 6 resolutions.3 × 3 mm Scan6 × 6 mm Scan Parameters Whole Image SCP VD (%)Fovea SCP VD (%)Parafovea SCP VD (%)Whole Image DCP VD (%)Fovea DCP VD (%)Parafovea DCP VD (%)FAZ Area (mm2)FD-300 (%)Whole Image SCP VD (%)Whole Image DCP VD (%)BMIr = 0.076, P = 0.117P†=0.244r = 0.042, P = 0.386 P†=0.540r = 0.073, P = 0.134 P†=0.275r=-0.038, P = 0.43 P†=0.579r = 0.066, P = 0.172 P†=0.326r=-0.05, P = 0.307 P†=0.464r=-0.049, P = 0.319 P†=0.475r=-0.002, P = 0.962 P†=0.966r=-0.014, P = 0.781, P†=0.843r=-0.066, P = 0.175, P†=0.325TBWr = 0.044, P = 0.369P†=0.519r = 0.230**, P = < 0.001 P†=0.003r = 0.016, P = 0.737 P†=0.790r=-178**, P = < 0.001P†= 0.003r = 0.229**, P = < 0.001 P†=0.003r=-0.263**, P = < 0.001 P†=0.003r=-236**, P = < 0.001 P†= 0.003r=-0.103*, P = 0.033 P†=0.082r=-0.149*, P = 0.002, P†=0.035r=-0.094, P = 0.054, P†=0.181ICWr = 0.046, P = 0.347P†=0.501r = 0.230**, P = < 0.001 P†=0.003r = 0.018, P = 0.71 P†=0.769r=-161**, P = 0.001 P†= 0.003r=-260**, P = < 0.001 P†=0.003r=-0.246**, P = < 0.001 P†=0.003r=-235**, P = < 0.001 P†= 0.003r=-0.100*, P = 0.039 P†=0.094r=-0.146*, P = 0.003, P†=0.044r=-0.091, P = 0.06, P†=0.181ECWr = 0.04, P = 0.41P†=0.564r = 0.229**, P = < 0.001 P†=0.003r = 0.013, P = 0.786 P†=0.824r=-182**, P = < 0.001 P†= 0.003r = 0.227**, P = < 0.001 P†=0.003r=-0.266**, P = < 0.001 P†=0.003r=-237**, P = < 0.001 P†= 0.003r=-0.108*, P = 0.026 P†=0.066r=-0.154*, P = 0.001, P†=0.024r=-0.097*, P = 0.046, P†=0.165Proteinr=-0.035, P = 0.476P†=0.611r=-0.067, P = 0.168 P†=0.320r=-0.026, P = 0.591 P†=0.692r=-0.033, P = 0.499 P†=0.627r=-0.058, P = 0.235 P†=0.388r=-0.032, P = 0.507 P†=0.631r = 0.036, P = 0.468 P†=0.605r=-0.057, P = 0.245 P†=0.393r = 0.003, P = 0.944, P†=0.959r = 0.058, P = 0.235, P†=0.395Mineralsr = 0.07, P = 0.153P†=0.301r = 0.204**, P = < 0.001 P†=0.003r = 0.045, P = 0.354 P†=0.504r=-163**, P = 0.001 P†= 0.003r = 0.207**, P = < 0.001 P†=0.003r=-0.241**, P = < 0.001 P†=0.003r=-211**, P = < 0.001 P†= 0.003r=-0.081, P = 0.095 P†=0.206r=-0.118*, P = 0.015, P†=0.106r=-0.091, P = 0.06, P†=0.181BFMr = 0.065, P = 0.182P†=0.334r=-0.023, P = 0.632 P†=0.723r = 0.064, P = 0.185 P†=0.336r = 0.019, P = 0.689 P†=0.758r = 0.006, P = 0.897 P†=0.914r = 0.029, P = 0.558 P†=0.666r = 0.005, P = 0.917 P†=0.930r=-0.007, P = 0.889 P†=0.907r = 0.039, P = 0.422, P†=0.531r=-0.045, P = 0.361, P†=0.497SLMr = 0.065, P = 0.182P†=0.334r=-0.023, P = < 0.001 P†=0.003r = 0.064, P = 0.185 P†=0.336r = 0.019, P = < 0.001 P†=0.003r = 0.006, P = < 0.001 P†=0.003r = 0.029, P = < 0.001 P†=0.003r = 0.005, P = < 0.001 P†= 0.003r=-0.007, P = 0.889 P†=0.907r = 0.039, P = 0.422, P†=0.531r=-0.045, P = 0.361, P†=0.497FFMr = 0.046, P = 0.348 P†=0.501r = 0.228**, P = < 0.001 P†=0.003r = 0.018, P = 0.706 P†=0.768r=-177**, P = < 0.001 P†=0.003r = 0.227**, P = < 0.001 P†=0.003r=-0.261**, P = < 0.001P†=0.003r=-234**, P = < 0.001 P†= 0.003r=-0.102*, P = 0.037 P†=0.091r=-0.147*, P = 0.002, P†=0.035r=-0.093, P = 0.056, P†=0.181SMMr = 0.046, P = 0.349P†=0.501r = 0.230**, P = < 0.001 P†=0.003r = 0.018, P = 0.713 P†=0.769r=-0.176**, P = < 0.001 P†=0.003r=-0.260**, P = < 0.001 P†=0.003r=-0.260**, P = < 0.001 P†=0.003r=-0.236**, P = < 0.001 P†=0.003r=-0.100*, P = 0.039 P†=0.094r=-0.146*, P = 0.003, P†=0.044r=-0.091, P = 0.06, P†=0.181PBFr = 0.035, P = 0.467 P†=0.605r=-0.155**, P = 0.001 P†=0.003r = 0.052, P = 0.284 P†=0.436r = 0.124*, P = 0.011 P†=0.029r = 0.179**, P = < 0.001 P†=0.003r = 0.179**, P = < 0.001 P†=0.003r = 0.148**, P = 0.002P†=0.006r = 0.073, P = 0.132 P†=0.272r = 0.122*, P = 0.012, P†=0.106r = 0.019, P = 0.691, P†=0.768BMRr = 0.045, P = 0.35 P†=0.501r = 0.228**, P = < 0.001 P†=0.003r = 0.018, P = 0.709 P†=0.769r=-0.177**, P = < 0.001 P†=0.003r=-0.261**, P = < 0.001 P†=0.003r=-0.261**, P = < 0.001 P†=0.003r=-0.234**, P = < 0.002P†=0.006r=-0.102*, P = 0.037 P†=0.091r=-0.147*, P = 0.002, P†=0.035r=-0.093, P = 0.056, P†=0.181WHRr = 0.059, P = 0.223 P†=0.383r = 0.135** P = 0.005 P†=0.015r = 0.04, P = 0.414 P†=0.568r=-0.072, P = 0.14 P†=0.285r=-0.112*, P = 0.021 P†=0.054r=-0.112*, P = 0.021 P†=0.054r=-0.234**, P = < 0.001 P†=0.003r=-161**, P = 0.001 P†=0.003r=-0.051, P = 0.293, P†=0.464r=-0.081, P = 0.096, P†=0.211VFAr = 0.06, P = 0.217 P†=0.381r=-0.054, P = 0.268 P†=0.416r = 0.065, P = 0.18 P†=0.334r = 0.037, P = 0.448 P†=0.593r = 0.057, P = 0.239 P†=0.389r = 0.057, P = 0.239 P†=0.389r = 0.038, P = 0.435 P†=0.582r = 0.008, P = 0.872 P†=0.899r = 0.062, P = 0.203, P†=0.360r=-0.041, P = 0.395, P†=0.526PhAr = 0.036, P = 0.454 P†=0.598r = 0.174**, P = < 0.001 P†=0.003r = 0.013, P = 0.784 P†=0.824r=-0.083, P = 0.088 P†=0.195r=-0.138**, P = 0.004 P†=0.012r=-0.138**, P = 0.004 P†=0.012r=-0.169**, P = < 0.001 P†=0.003r=-0.036, P = 0.463 P†=0.605r=-0.06, P = 0.221, P†=0.378r = 0.002, P = 0.962, P†=0.968NCr = 0.034,P = 0.485 P†=0.617r = 0.223**,P = < 0.001 P†=0.003r = 0.007,P = 0.888 P†=0.907r=-0.154**,P = 0.001 P†=0.003r=-0.227**,P = < 0.001 P†=0.003r=-0.227**,P = < 0.001 P†=0.003r=-0.233**,P = < 0.001 P†=0.003r=-127**,P = 0.009 P†=0.025r=-0.133*, P = 0.006, P†=0.076r=-0.101*, P = 0.039, P†=0.151CCr = 0.071,P = 0.146 P†=0.293r = 0.194**,P = < 0.001 P†=0.003r = 0.048,P = 0.326 P†=0.484r=-0.144**,P = 0.003 P†=0.009r=-0.210**,P = < 0.001 P†=0.003r=-0.210**,P = < 0.001 P†=0.003r=-0.200**,P = < 0.001 P†=0.003r=-0.081,P = 0.094 P†=0.025r=-0.107*, P = 0.027, P†=0.112r=-0.099, P = 0.041, P†=0.156ACr = 0.078,P = 0.109 P†=0.299r = 0.136**,P = 0.005 P†=0.015r = 0.059,P = 0.228 P†=0.383r=-0.09,P = 0.065 P†=0.150r=-0.134**,P = 0.006 P†=0.017r=-0.134**,P = 0.006 P†=0.017r=-0.149**,P = 0.002 P†=0.006r=-0.075,P = 0.126 P†=0.260r=-0.059, P = 0.224, P†=0.380r=-0.091, P = 0.062, P†=0.181HCr = 0.084,P = 0.085 P†=0.191r = 0.111*,P = 0.022 P†=0.056r = 0.07,P = 0.152 P†=0.300r=-0.088,P = 0.07 P†=0.160r=-0.129**,P = 0.008 P†=0.022r=-0.129**,P = 0.008 P†=0.022r=-0.124*,P = 0.011 P†=0.029r=-0.045,P = 0.359 P†=0.508r=-0.055, P = 0.257, P†=0.417r=-0.085, P = 0.081, P†=0.197P† = Benjamini–Hochberg FDR-adjusted P (q = 0.05). **Correlation is significant at the 0.01 level (2-tailed). *Correlation is significant at the 0.05 level (2-tailed). OCTA: optical coherence tomography angiography, VD: vessel density, SCP: superficial capillary plexus, DCP: deep capillary plexus, BMI: body mass Index, TBW: total body Water, ICW: intracellular Water, ECW: extracellular Water, BFM: body fat mass, SLM: soft lean mass, FFM: fat free mass, SMM: skeletal muscle mass, PBF: percent body fat, BMR: basal metabolic Rate, WHR: Waist-Hip Ratio, VFA: visceral fat Area, pha: whole body phase Angle, NC: neck Circumference, CC: chest Circumference, AC: abdomen Circumference, HC: hip Circumference. Table 3Correlation of the inbody 770 body analyzer parameters and the macular OCTA imaging parameters in 3 × 3 and 6 × 6 resolutions.3 × 3 mm Scan6 × 6 mm Scan Parameters Whole Image SCP VD (%)Fovea SCP VD (%)Parafovea SCP VD (%)Whole Image DCP VD (%)Fovea DCP VD (%)Parafovea DCP VD (%)FAZ Area (mm2)FD-300 (%)Whole Image SCP VD (%)Whole Image DCP VD (%)BMIr = 0.076, P = 0.117P†=0.244r = 0.042, P = 0.386 P†=0.540r = 0.073, P = 0.134 P†=0.275r=-0.038, P = 0.43 P†=0.579r = 0.066, P = 0.172 P†=0.326r=-0.05, P = 0.307 P†=0.464r=-0.049, P = 0.319 P†=0.475r=-0.002, P = 0.962 P†=0.966r=-0.014, P = 0.781, P†=0.843r=-0.066, P = 0.175, P†=0.325TBWr = 0.044, P = 0.369P†=0.519r = 0.230**, P = < 0.001 P†=0.003r = 0.016, P = 0.737 P†=0.790r=-178**, P = < 0.001P†= 0.003r = 0.229**, P = < 0.001 P†=0.003r=-0.263**, P = < 0.001 P†=0.003r=-236**, P = < 0.001 P†= 0.003r=-0.103*, P = 0.033 P†=0.082r=-0.149*, P = 0.002, P†=0.035r=-0.094, P = 0.054, P†=0.181ICWr = 0.046, P = 0.347P†=0.501r = 0.230**, P = < 0.001 P†=0.003r = 0.018, P = 0.71 P†=0.769r=-161**, P = 0.001 P†= 0.003r=-260**, P = < 0.001 P†=0.003r=-0.246**, P = < 0.001 P†=0.003r=-235**, P = < 0.001 P†= 0.003r=-0.100*, P = 0.039 P†=0.094r=-0.146*, P = 0.003, P†=0.044r=-0.091, P = 0.06, P†=0.181ECWr = 0.04, P = 0.41P†=0.564r = 0.229**, P = < 0.001 P†=0.003r = 0.013, P = 0.786 P†=0.824r=-182**, P = < 0.001 P†= 0.003r = 0.227**, P = < 0.001 P†=0.003r=-0.266**, P = < 0.001 P†=0.003r=-237**, P = < 0.001 P†= 0.003r=-0.108*, P = 0.026 P†=0.066r=-0.154*, P = 0.001, P†=0.024r=-0.097*, P = 0.046, P†=0.165Proteinr=-0.035, P = 0.476P†=0.611r=-0.067, P = 0.168 P†=0.320r=-0.026, P = 0.591 P†=0.692r=-0.033, P = 0.499 P†=0.627r=-0.058, P = 0.235 P†=0.388r=-0.032, P = 0.507 P†=0.631r = 0.036, P = 0.468 P†=0.605r=-0.057, P = 0.245 P†=0.393r = 0.003, P = 0.944, P†=0.959r = 0.058, P = 0.235, P†=0.395Mineralsr = 0.07, P = 0.153P†=0.301r = 0.204**, P = < 0.001 P†=0.003r = 0.045, P = 0.354 P†=0.504r=-163**, P = 0.001 P†= 0.003r = 0.207**, P = < 0.001 P†=0.003r=-0.241**, P = < 0.001 P†=0.003r=-211**, P = < 0.001 P†= 0.003r=-0.081, P = 0.095 P†=0.206r=-0.118*, P = 0.015, P†=0.106r=-0.091, P = 0.06, P†=0.181BFMr = 0.065, P = 0.182P†=0.334r=-0.023, P = 0.632 P†=0.723r = 0.064, P = 0.185 P†=0.336r = 0.019, P = 0.689 P†=0.758r = 0.006, P = 0.897 P†=0.914r = 0.029, P = 0.558 P†=0.666r = 0.005, P = 0.917 P†=0.930r=-0.007, P = 0.889 P†=0.907r = 0.039, P = 0.422, P†=0.531r=-0.045, P = 0.361, P†=0.497SLMr = 0.065, P = 0.182P†=0.334r=-0.023, P = < 0.001 P†=0.003r = 0.064, P = 0.185 P†=0.336r = 0.019, P = < 0.001 P†=0.003r = 0.006, P = < 0.001 P†=0.003r = 0.029, P = < 0.001 P†=0.003r = 0.005, P = < 0.001 P†= 0.003r=-0.007, P = 0.889 P†=0.907r = 0.039, P = 0.422, P†=0.531r=-0.045, P = 0.361, P†=0.497FFMr = 0.046, P = 0.348 P†=0.501r = 0.228**, P = < 0.001 P†=0.003r = 0.018, P = 0.706 P†=0.768r=-177**, P = < 0.001 P†=0.003r = 0.227**, P = < 0.001 P†=0.003r=-0.261**, P = < 0.001P†=0.003r=-234**, P = < 0.001 P†= 0.003r=-0.102*, P = 0.037 P†=0.091r=-0.147*, P = 0.002, P†=0.035r=-0.093, P = 0.056, P†=0.181SMMr = 0.046, P = 0.349P†=0.501r = 0.230**, P = < 0.001 P†=0.003r = 0.018, P = 0.713 P†=0.769r=-0.176**, P = < 0.001 P†=0.003r=-0.260**, P = < 0.001 P†=0.003r=-0.260**, P = < 0.001 P†=0.003r=-0.236**, P = < 0.001 P†=0.003r=-0.100*, P = 0.039 P†=0.094r=-0.146*, P = 0.003, P†=0.044r=-0.091, P = 0.06, P†=0.181PBFr = 0.035, P = 0.467 P†=0.605r=-0.155**, P = 0.001 P†=0.003r = 0.052, P = 0.284 P†=0.436r = 0.124*, P = 0.011 P†=0.029r = 0.179**, P = < 0.001 P†=0.003r = 0.179**, P = < 0.001 P†=0.003r = 0.148**, P = 0.002P†=0.006r = 0.073, P = 0.132 P†=0.272r = 0.122*, P = 0.012, P†=0.106r = 0.019, P = 0.691, P†=0.768BMRr = 0.045, P = 0.35 P†=0.501r = 0.228**, P = < 0.001 P†=0.003r = 0.018, P = 0.709 P†=0.769r=-0.177**, P = < 0.001 P†=0.003r=-0.261**, P = < 0.001 P†=0.003r=-0.261**, P = < 0.001 P†=0.003r=-0.234**, P = < 0.002P†=0.006r=-0.102*, P = 0.037 P†=0.091r=-0.147*, P = 0.002, P†=0.035r=-0.093, P = 0.056, P†=0.181WHRr = 0.059, P = 0.223 P†=0.383r = 0.135** P = 0.005 P†=0.015r = 0.04, P = 0.414 P†=0.568r=-0.072, P = 0.14 P†=0.285r=-0.112*, P = 0.021 P†=0.054r=-0.112*, P = 0.021 P†=0.054r=-0.234**, P = < 0.001 P†=0.003r=-161**, P = 0.001 P†=0.003r=-0.051, P = 0.293, P†=0.464r=-0.081, P = 0.096, P†=0.211VFAr = 0.06, P = 0.217 P†=0.381r=-0.054, P = 0.268 P†=0.416r = 0.065, P = 0.18 P†=0.334r = 0.037, P = 0.448 P†=0.593r = 0.057, P = 0.239 P†=0.389r = 0.057, P = 0.239 P†=0.389r = 0.038, P = 0.435 P†=0.582r = 0.008, P = 0.872 P†=0.899r = 0.062, P = 0.203, P†=0.360r=-0.041, P = 0.395, P†=0.526PhAr = 0.036, P = 0.454 P†=0.598r = 0.174**, P = < 0.001 P†=0.003r = 0.013, P = 0.784 P†=0.824r=-0.083, P = 0.088 P†=0.195r=-0.138**, P = 0.004 P†=0.012r=-0.138**, P = 0.004 P†=0.012r=-0.169**, P = < 0.001 P†=0.003r=-0.036, P = 0.463 P†=0.605r=-0.06, P = 0.221, P†=0.378r = 0.002, P = 0.962, P†=0.968NCr = 0.034,P = 0.485 P†=0.617r = 0.223**,P = < 0.001 P†=0.003r = 0.007,P = 0.888 P†=0.907r=-0.154**,P = 0.001 P†=0.003r=-0.227**,P = < 0.001 P†=0.003r=-0.227**,P = < 0.001 P†=0.003r=-0.233**,P = < 0.001 P†=0.003r=-127**,P = 0.009 P†=0.025r=-0.133*, P = 0.006, P†=0.076r=-0.101*, P = 0.039, P†=0.151CCr = 0.071,P = 0.146 P†=0.293r = 0.194**,P = < 0.001 P†=0.003r = 0.048,P = 0.326 P†=0.484r=-0.144**,P = 0.003 P†=0.009r=-0.210**,P = < 0.001 P†=0.003r=-0.210**,P = < 0.001 P†=0.003r=-0.200**,P = < 0.001 P†=0.003r=-0.081,P = 0.094 P†=0.025r=-0.107*, P = 0.027, P†=0.112r=-0.099, P = 0.041, P†=0.156ACr = 0.078,P = 0.109 P†=0.299r = 0.136**,P = 0.005 P†=0.015r = 0.059,P = 0.228 P†=0.383r=-0.09,P = 0.065 P†=0.150r=-0.134**,P = 0.006 P†=0.017r=-0.134**,P = 0.006 P†=0.017r=-0.149**,P = 0.002 P†=0.006r=-0.075,P = 0.126 P†=0.260r=-0.059, P = 0.224, P†=0.380r=-0.091, P = 0.062, P†=0.181HCr = 0.084,P = 0.085 P†=0.191r = 0.111*,P = 0.022 P†=0.056r = 0.07,P = 0.152 P†=0.300r=-0.088,P = 0.07 P†=0.160r=-0.129**,P = 0.008 P†=0.022r=-0.129**,P = 0.008 P†=0.022r=-0.124*,P = 0.011 P†=0.029r=-0.045,P = 0.359 P†=0.508r=-0.055, P = 0.257, P†=0.417r=-0.085, P = 0.081, P†=0.197P† = Benjamini–Hochberg FDR-adjusted P (q = 0.05). **Correlation is significant at the 0.01 level (2-tailed). *Correlation is significant at the 0.05 level (2-tailed). OCTA: optical coherence tomography angiography, VD: vessel density, SCP: superficial capillary plexus, DCP: deep capillary plexus, BMI: body mass Index, TBW: total body Water, ICW: intracellular Water, ECW: extracellular Water, BFM: body fat mass, SLM: soft lean mass, FFM: fat free mass, SMM: skeletal muscle mass, PBF: percent body fat, BMR: basal metabolic Rate, WHR: Waist-Hip Ratio, VFA: visceral fat Area, pha: whole body phase Angle, NC: neck Circumference, CC: chest Circumference, AC: abdomen Circumference, HC: hip Circumference. Correlation of the inbody 770 body analyzer parameters and the macular OCTA imaging parameters in 3 × 3 and 6 × 6 resolutions. r = 0.076, P = 0.117 P†=0.244 r = 0.044, P = 0.369 P†=0.519 r=-178**, P = < 0.001 P†= 0.003 r = 0.046, P = 0.347 P†=0.501 r = 0.04, P = 0.41 P†=0.564 r=-0.035, P = 0.476 P†=0.611 r = 0.07, P = 0.153 P†=0.301 r = 0.065, P = 0.182 P†=0.334 r = 0.065, P = 0.182 P†=0.334 r=-0.261**, P = < 0.001 P†=0.003 r = 0.046, P = 0.349 P†=0.501 r = 0.148**, P = 0.002 P†=0.006 r=-0.234**, P = < 0.002 P†=0.006 r = 0.034, P = 0.485 P†=0.617 r = 0.223**, P = < 0.001 P†=0.003 r = 0.007, P = 0.888 P†=0.907 r=-0.154**, P = 0.001 P†=0.003 r=-0.227**, P = < 0.001 P†=0.003 r=-0.227**, P = < 0.001 P†=0.003 r=-0.233**, P = < 0.001 P†=0.003 r=-127**, P = 0.009 P†=0.025 r = 0.071, P = 0.146 P†=0.293 r = 0.194**, P = < 0.001 P†=0.003 r = 0.048, P = 0.326 P†=0.484 r=-0.144**, P = 0.003 P†=0.009 r=-0.210**, P = < 0.001 P†=0.003 r=-0.210**, P = < 0.001 P†=0.003 r=-0.200**, P = < 0.001 P†=0.003 r=-0.081, P = 0.094 P†=0.025 r = 0.078, P = 0.109 P†=0.299 r = 0.136**, P = 0.005 P†=0.015 r = 0.059, P = 0.228 P†=0.383 r=-0.09, P = 0.065 P†=0.150 r=-0.134**, P = 0.006 P†=0.017 r=-0.134**, P = 0.006 P†=0.017 r=-0.149**, P = 0.002 P†=0.006 r=-0.075, P = 0.126 P†=0.260 r = 0.084, P = 0.085 P†=0.191 r = 0.111*, P = 0.022 P†=0.056 r = 0.07, P = 0.152 P†=0.300 r=-0.088, P = 0.07 P†=0.160 r=-0.129**, P = 0.008 P†=0.022 r=-0.129**, P = 0.008 P†=0.022 r=-0.124*, P = 0.011 P†=0.029 r=-0.045, P = 0.359 P†=0.508 P† = Benjamini–Hochberg FDR-adjusted P (q = 0.05). **Correlation is significant at the 0.01 level (2-tailed). *Correlation is significant at the 0.05 level (2-tailed). OCTA: optical coherence tomography angiography, VD: vessel density, SCP: superficial capillary plexus, DCP: deep capillary plexus, BMI: body mass Index, TBW: total body Water, ICW: intracellular Water, ECW: extracellular Water, BFM: body fat mass, SLM: soft lean mass, FFM: fat free mass, SMM: skeletal muscle mass, PBF: percent body fat, BMR: basal metabolic Rate, WHR: Waist-Hip Ratio, VFA: visceral fat Area, pha: whole body phase Angle, NC: neck Circumference, CC: chest Circumference, AC: abdomen Circumference, HC: hip Circumference. Discussion Our study represents the first comprehensive investigation of the relationship between macular VD and FAZ parameters, as measured by OCTA, and anthropometric indices obtained from the InBody 770 body analyzer in a large cohort of healthy adults. These findings illuminate the intricate interplay between systemic physical health markers and retinal microvasculature, contributing to the expanding body of evidence linking systemic health to ocular well-being. This study revealed significant correlations between anthropometric indices and OCTA-derived parameters. All associations we highlight remained significant after Benjamini–Hochberg FDR correction (q = 0.05); nominal findings that did not survive correction are not interpreted. Specifically, macular VD values in the SCP and DCP of the fovea were positively associated with lean body mass indices, including TBW, SMM, and FFM. Conversely, PBF, a marker of adiposity, was negatively correlated with these VDs, suggesting that excess body fat may adversely affect macular perfusion. These findings align with prior studies reporting decreased macular VD in individuals with obesity and metabolic disorders16,17. While many associations reached statistical significance, their magnitudes were small, consistent with expectations in an ostensibly healthy cohort with restricted exposure and outcome ranges and with OCTA metrics influenced by multiple biological determinants. Accordingly, these results should not be interpreted as evidence for clinical decision-making or screening at the individual level; rather, they provide population-level signals that warrant confirmation and mechanistic follow-up. We observed a paradoxical pattern whereby foveal VD correlated positively with lean-mass markers (e.g., SMM, BMR), whereas parafoveal and whole-image DCP VD correlated negatively with the same indices. Plausible, non–mutually exclusive explanations include: (i) FAZ geometry can influence foveal VD estimates and inflate apparent associations; (ii) DCP metrics outside the fovea are more susceptible to segmentation and projection artifacts; and (iii) in healthy eyes, parafoveal VD shows restricted variance, which can yield small inverse correlations once multiple covarying anthropometric measures are tested. In addition, unmeasured axial length and small differences in scan quality may differentially affect foveal versus parafoveal/DCP measurements. Given the modest effect sizes and cross-sectional design, these patterns should be interpreted cautiously and may partly reflect residual noise. Prospective imaging and mechanistic studies are needed to clarify these region-specific signals. Sex-based differences in retinal vascular parameters were also evident, with females exhibiting higher parafoveal DCP VD values. This disparity may reflect systemic vascular and body composition differences influenced by sex18. Similar trends observed in other OCTA-based studies emphasize the necessity of accounting for sex as a variable in retinal vascular assessments19. The mechanistic underpinnings of these observations may be attributed to systemic factors such as arterial stiffness and metabolic health, which can modulate ocular blood flow. Reduced systemic vascular elasticity and endothelial dysfunction hinder ocular perfusion, as reflected by the significant negative correlation between PhA, a stiffness marker, and parafoveal DCP VD in our study20. Moreover, lean body mass may protect ocular perfusion by promoting cardiovascular health21,22. However, no significant correlations were found between SLM or BFM, and macular VD in our population. Unlike BMI-focused studies, our investigation incorporated multiple anthropometric indices, offering a broader perspective on the interplay between body composition and macular VD. Ozgure et al. reported no correlation between BMI and macular SCP/DCP VDs but observed significant negative associations with choroidal thickness and FAZ depth16. In contrast, Ding et al. found a positive association between BMI and macular SCP/DCP VDs23. Studies by Dogan et al. and Li et al. linked reduced SCP and DCP VDs with obesity and poor glycemic control, respectively6,17. Notably, while the mean BMI of our subjects was 26.1 ± 3.5 kg/m², we found no significant correlation between BMI and macular VDs, suggesting that other anthropometric factors may play more critical roles in healthy populations. Our findings corroborate prior research on the WHR, where Ding et al. observed a positive association with SCP and DCP VDs in the macular inner circle23. Similarly, we identified a significant positive correlation between WHR and foveal VD values but a negative association with parafoveal DCP VDs. This suggests that abdominal obesity may exert localized effects on the macular microvasculature. Additional positive correlations between foveal SCP/DCP VDs and other circumferential measures, including neck, chest, abdominal, and hip circumferences, further highlight the systemic interconnections between body composition and ocular vascular health. The associations between lean body mass and macular VDs underscore the protective role of lean mass in maintaining retinal perfusion, aligning with literature highlighting its systemic benefits, including reduced arterial stiffness and enhanced microvascular circulation24. Conversely, the detrimental impact of adiposity on retinal microcirculation is well-documented, with mechanisms such as chronic inflammation, oxidative stress, and endothelial dysfunction contributing to impaired retinal vascular integrity25. The interaction between systemic anthropometric indices and retinal microvasculature can be speculatively attributed to several proposed mechanisms, such as:Endothelial Dysfunction: Obesity and metabolic syndrome can disrupt endothelial nitric oxide production, reducing vasodilation and retinal blood flow25,26.Inflammation and Oxidative Stress: Elevated adiposity triggers chronic inflammation and oxidative stress, with pro-inflammatory cytokines (e.g., TNF-α, IL-6) compromising the blood-retinal barrier and promoting vascular damage27.Arterial Stiffness: Arterial rigidity, reflected by decreased PhA, reduces vascular compliance, impairing ocular perfusion due to diminished autoregulatory capacity28.Hemodynamic Changes: Obesity-induced hemodynamic alterations, such as elevated central venous pressure, may further compromise retinal perfusion29. Endothelial Dysfunction: Obesity and metabolic syndrome can disrupt endothelial nitric oxide production, reducing vasodilation and retinal blood flow25,26. Endothelial Dysfunction: Obesity and metabolic syndrome can disrupt endothelial nitric oxide production, reducing vasodilation and retinal blood flow25,26. Inflammation and Oxidative Stress: Elevated adiposity triggers chronic inflammation and oxidative stress, with pro-inflammatory cytokines (e.g., TNF-α, IL-6) compromising the blood-retinal barrier and promoting vascular damage27. Inflammation and Oxidative Stress: Elevated adiposity triggers chronic inflammation and oxidative stress, with pro-inflammatory cytokines (e.g., TNF-α, IL-6) compromising the blood-retinal barrier and promoting vascular damage27. Arterial Stiffness: Arterial rigidity, reflected by decreased PhA, reduces vascular compliance, impairing ocular perfusion due to diminished autoregulatory capacity28. Arterial Stiffness: Arterial rigidity, reflected by decreased PhA, reduces vascular compliance, impairing ocular perfusion due to diminished autoregulatory capacity28. Hemodynamic Changes: Obesity-induced hemodynamic alterations, such as elevated central venous pressure, may further compromise retinal perfusion29. Hemodynamic Changes: Obesity-induced hemodynamic alterations, such as elevated central venous pressure, may further compromise retinal perfusion29. The observed higher parafoveal DCP VD in females warrants further investigation. Hormonal factors, particularly estrogen’s vascular protective effects, may play a pivotal role. Estrogen’s enhancement of endothelial function and microvascular perfusion could underlie these differences, highlighting the need to consider hormonal and menopausal status in future studies30. Our study has several notable strengths. First, we leveraged a large, population-based cohort of 424 healthy adults, ensuring robust statistical power to detect even modest associations. Second, we combined high-resolution 3 × 3 mm and 6 × 6 mm OCTA scans with comprehensive body-composition profiling via the InBody 770 analyzer, allowing simultaneous evaluation of both microvascular and anthropometric parameters. Third, by analyzing a broad spectrum of lean-mass and adiposity indices—instead of relying solely on BMI—we provide a deeper, multidimensional understanding of how systemic body composition relates to macular perfusion. Fourth, strict image-quality criteria and expert review minimized segmentation errors, enhancing the reliability of our OCTA measurements. Finally, sex-stratified analyses shed light on gender differences in retinal microvasculature, emphasizing the importance of tailoring ocular assessments to demographic factors. However, this study has several limitations. Its cross-sectional design precludes causal inference between anthropometric indices and retinal microvasculature and raises the possibility of reverse causality—for example, systemic vascular health might influence body composition metrics rather than vice versa. Our cohort comprised ostensibly healthy adults from a single center, which may limit generalizability to other ethnic groups or to patients with systemic diseases. Residual confounding from unmeasured factors - such as hematocrit, dietary patterns, glycemic status, and physical activity - cannot be excluded. Although we controlled the false discovery rate (Benjamini–Hochberg, q = 0.05) within families of tests, residual Type I error is still possible; therefore, findings should be confirmed in independent cohorts. Although we attempted to reduce refractive error–related confounding by excluding high ametropia, the absence of axial length measurements remains a limitation that may affect OCTA magnification and vessel density estimates. We also analyzed only right eyes to maximize image quality, a choice that may introduce systematic bias relative to random-eye selection or inter-eye statistical modeling. Although bio-impedance analysis provided valuable body-composition insights, it is less precise than gold-standard techniques such as dual-energy X-ray absorptiometry (DXA). Finally, the observed effects were small; despite FDR control, these statistically significant associations have limited clinical relevance and should be considered hypothesis-generating until replicated and linked to clinical endpoints. Longitudinal studies are essential to establish causality between systemic health changes and retinal vascular alterations. Investigating the impact of targeted interventions, such as weight loss, exercise, and pharmacological treatments, on retinal vascular health could inform therapeutic strategies. Including populations with systemic diseases, such as diabetes and hypertension, would enhance the generalizability of these findings. In summary, we found that foveal SCP and DCP vessel densities were positively correlated with lean body mass indices (TBW, SMM, FFM, BMR, and WHR) and negatively correlated with percent body fat (PBF). Whole-image DCP VD, FAZ area, perimeter, and FD-300 showed significant negative associations with TBW, ICW, ECW, FFM, SMM, BMR, NC, CC, AC, and HC. Sex-specific analysis demonstrated higher foveal SCP VD in males and elevated parafoveal DCP VD, FAZ area, perimeter, and FD-300 in females. While our findings highlight associations between body-composition metrics and macular microvasculature, causality cannot be inferred from this cross‐sectional analysis. Prospective and interventional studies are required to determine the directionality of these relationships and to control for unmeasured confounders. By integrating retinal imaging into broader health monitoring frameworks, clinicians could implement personalized preventative strategies, ultimately improving systemic and ocular health outcomes. Future research should continue to elucidate the mechanisms driving these associations and evaluate the efficacy of targeted interventions. Given the small, region-specific effect sizes and the cross-sectional design, these findings should be viewed as hypothesis-generating signals that require replication in independent cohorts and linkage to clinical endpoints before informing practice. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1